Christophe Bourdon, Orphazyme CEO

Or­p­hazyme CEO de­parts for Leo Phar­ma as both com­pa­nies face ma­jor re­struc­tur­ings

Some­one else, it seems, will get the op­por­tu­ni­ty of try­ing to steer Or­p­hazyme back to its for­mer meme­land glo­ry.

In a bit of Dan­ish biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.